Weimar W - Search Results

1

Mycophenolate mofetil and prednisone as maintenance treatment after kidney transplantation.

van Gelder T, Klaassen RJ, van Riemsdijk-van Overbeeke I, IJzermans JN, Weimar W. van Gelder T, et al. Among authors: weimar w. Transplantation. 1997 May 27;63(10):1530-1. doi: 10.1097/00007890-199705270-00029. Transplantation. 1997. PMID: 9175824

2

Successful treatment of Kaposi's sarcoma in a renal allograft recipient.

Marsman WA, Van Gelder T, Mulder AH, Ijzermans JN, Zietse R, Weimar W. Marsman WA, et al. Among authors: weimar w. Nephrol Dial Transplant. 1995;10(6):900-1. Nephrol Dial Transplant. 1995. PMID: 7566628 No abstract available.

3

A double-blind, placebo-controlled study of monoclonal anti-interleukin-2 receptor antibody (BT563) administration to prevent acute rejection after kidney transplantation.

van Gelder T, Zietse R, Mulder AH, Yzermans JN, Hesse CJ, Vaessen LM, Weimar W. van Gelder T, et al. Among authors: weimar w. Transplantation. 1995 Aug 15;60(3):248-52. doi: 10.1097/00007890-199508000-00007. Transplantation. 1995. PMID: 7645037 Clinical Trial.

4

Peripheral blood monitoring during and after rejection-prophylaxis with a monoclonal anti-interleukin-2-receptor antibody in kidney and heart transplant recipients.

van Gelder T, Knoop CJ, Hesse CJ, Vaessen LM, Balk AH, Yzermans JN, Weimar W. van Gelder T, et al. Among authors: weimar w. Transplant Proc. 1995 Feb;27(1):856-8. Transplant Proc. 1995. PMID: 7879206 Clinical Trial. No abstract available.

5

van Gelder T, Kroes LC, Mulder A, Gratama JW, Weimar W. van Gelder T, et al. Among authors: weimar w. Transplantation. 1994 Oct 15;58(7):852-5. Transplantation. 1994. PMID: 7940722 No abstract available.

6

Single-shot, high-dose rabbit ATG for rejection prophylaxis after kidney transplantation.

Zietse R, van Steenberge EP, Hesse CJ, Vaessen LB, IJzermans JN, Weimar W. Zietse R, et al. Among authors: weimar w. Transpl Int. 1993;6(6):337-40. doi: 10.1007/BF00335971. Transpl Int. 1993. PMID: 8297463

7

A randomized trial comparing safety and efficacy of OKT3 and a monoclonal anti-interleukin-2 receptor antibody (BT563) in the prevention of acute rejection after heart transplantation.

van Gelder T, Balk AH, Jonkman FA, Zietse R, Zondervan P, Hesse CJ, Vaessen LM, Mochtar B, Weimar W. van Gelder T, et al. Among authors: weimar w. Transplantation. 1996 Jul 15;62(1):51-5. doi: 10.1097/00007890-199607150-00011. Transplantation. 1996. PMID: 8693545 Clinical Trial.

8

Long-term follow-up after induction treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in kidney allograft recipients: a double-blind, placebo-controlled trial.

van Gelder T, Zietse R, Yzermans JN, Rischen-Vos J, Vaessen LM, Weimar W. van Gelder T, et al. Among authors: weimar w. Transplant Proc. 1996 Dec;28(6):3221-2. Transplant Proc. 1996. PMID: 8962247 Clinical Trial. No abstract available.

9

Steroid resistance in clinical heart transplantation: the role of simultaneous IL-2 and IL-4 mRNA expression.

Baan CC, Niesters HG, Balk AH, Mochtar B, Zondervan PE, van Gelder T, Weimar W. Baan CC, et al. Among authors: weimar w. Transplant Proc. 1996 Dec;28(6):3239-40. Transplant Proc. 1996. PMID: 8962254 No abstract available.

10

Losartan, an angiotensin-II receptor antagonist, reduces hematocrits in kidney transplant recipients with posttransplant erythrocytosis.

Klaassen RJ, van Gelder T, Rischen-Vos J, Deinum J, Man in't Veld AJ, Weimar W. Klaassen RJ, et al. Among authors: weimar w. Transplantation. 1997 Sep 15;64(5):780-2. doi: 10.1097/00007890-199709150-00023. Transplantation. 1997. PMID: 9311722

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

805 results

Search Page

Filters